Two Sigma Securities’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-39,553
Closed -$18K – 902
2016
Q2
$18K Buy
+39,553
New +$63.5K 0.01% 385

Other funds holding EPRS

Two Sigma Securities's EPRS Position: Q3 2016 in Review

Two Sigma Securities sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 39,553 shares — an estimated $18K sold.

Two Sigma Securities first reported a position in EPRS in Q2 2016 and held it in 1 quarter. The position peaked at $18K in Q2 2016. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

  • Two Sigma Securities reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
  • Two Sigma Securities sold 39,553 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $18K.
  • Two Sigma Securities first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q2 2016 and held it in 1 quarter.
  • Two Sigma Securities's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $18K in Q2 2016.
  • 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Two Sigma Securities's 13F filing for Q3 2016, filed 14 Nov 2016.